US equities |
MU $1,072.64 ▼-1.41% PLTR $199.25 ▲+2.64% NVDA $234.27 ▼-1.35% META $721.40 ▲+0.01% SNDK $1,645.08 ▼-2.80% GOOGL $353.04 ▲+0.72% AMD $635.09 ▼-1.67% INTC $109.80 ▼-2.93%
FinancialContent

Latest News about TCBPW

Recent news which mentions TCBPW

TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemia
Tickers TCBP TCBPW
Tags General Penny Stocks Benzinga
From Benzinga